Insider trades since May 15, 2026
10 insiders sold $53.0M on the market, none bought
Bought on the market
$0
0 trades
Sold on the market
$53.0M
63 trades by 10 insiders
Traded the most
George L. Sing
$20.4M Director
Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
Who traded
Buys and sales by insider
| Insider | Trades | Bought | Sold | Share of the total | Owned after | Latest |
|---|---|---|---|---|---|---|
| George L. Sing Director | 9 | - | $20.4M | 38% |
45,052 | Nov 2, 2026 |
| Huda Y. Zoghbi Director | 3 | - | $7.9M | 15% |
2,203 | Nov 3, 2026 |
| Christine A. Poon Director | 6 | - | $7.6M | 14% |
12,831 | Nov 2, 2026 |
| Joseph J. Larosa EVP General Counsel and Secret | 2 | - | $4.3M | 8% |
39,433 | Nov 2, 2026 |
| Jason Pitofsky SVP Controller | 8 | - | $3.8M | 7% |
7,716 | Nov 4, 2026 |
| Andrew J. Murphy Co-Chief Scientific Officer | 27 | - | $3.2M | 6% |
51,974 | Oct 14, 2026 |
| Marion McCourt EVP Commercial | 3 | - | $3.0M | 6% |
10,871 | Oct 30, 2026 |
| Michael S. Brown Director | 1 | - | $1.7M | 3% |
1,380 | Oct 30, 2026 |
| Kathryn Guarini Director | 3 | - | $1.0M | 2% |
603 | Oct 30, 2026 |
| Arthur F. Ryan Director | 1 | - | $130K | 0% |
17,303 | Jul 2, 2026 |
Every trade
Trade by trade, newest first
| Date | Insider | Role | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sale | -439 | 939.57 | 412K | 7,716 |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sale | -575 | 940.46 | 541K | 7,141 |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sale | -982 | 941.58 | 925K | 6,159 |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sale | -1,215 | 942.31 | 1.1M | 4,944 |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sale | -529 | 943.53 | 499K | 4,415 |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sale | -108 | 944.22 | 102K | 4,307 |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sale | -35 | 945.61 | 33K | 4,272 |
| Nov 4, 2026 | Jason Pitofsky (indirect) | SVP Controller | Sale | -179 | 950.76 | 170K | 0 |
| Nov 3, 2026 | Huda Y. Zoghbi | Director | Sale | -6,939 | 970.42 | 6.7M | 2,203 |
| Nov 3, 2026 | Huda Y. Zoghbi | Director | Sale | -500 | 971.06 | 486K | 1,703 |
| Nov 2, 2026 | Christine A. Poon | Director | Sale | -218 | 966.74 | 211K | 12,831 |
| Nov 2, 2026 | Christine A. Poon | Director | Sale | -772 | 967.38 | 747K | 12,059 |
| Nov 2, 2026 | Christine A. Poon | Director | Sale | -2,499 | 968.58 | 2.4M | 9,560 |
| Nov 2, 2026 | Christine A. Poon | Director | Sale | -3,203 | 969.50 | 3.1M | 6,357 |
| Nov 2, 2026 | Christine A. Poon | Director | Sale | -937 | 970.51 | 909K | 5,420 |
| Nov 2, 2026 | Christine A. Poon | Director | Sale | -201 | 971.31 | 195K | 5,219 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -1,224 | 960.57 | 1.2M | 45,052 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -540 | 961.85 | 519K | 44,512 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -2,522 | 962.61 | 2.4M | 41,990 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -4,338 | 963.47 | 4.2M | 37,652 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -2,670 | 964.57 | 2.6M | 34,982 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -7,073 | 965.38 | 6.8M | 27,909 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -1,522 | 966.27 | 1.5M | 26,387 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -1,040 | 967.07 | 1.0M | 25,347 |
| Nov 2, 2026 | George L. Sing | Director | Sale | -200 | 970.18 | 194K | 25,147 |
| Nov 2, 2026 | Joseph J. Larosa | EVP General Counsel and Secret | Sale | -3,939 | 965.41 | 3.8M | 39,433 |
| Nov 2, 2026 | Joseph J. Larosa | EVP General Counsel and Secret | Sale | -527 | 966.11 | 509K | 38,906 |
| Oct 30, 2026 | Michael S. Brown | Director | Sale (10b5-1) | -1,929 | 875.00 | 1.7M | 1,380 |
| Oct 30, 2026 | Marion McCourt | EVP Commercial | Sale (10b5-1) | -1,132 | 869.43 | 984K | 10,871 |
| Oct 30, 2026 | Kathryn Guarini | Director | Sale (10b5-1) | -400 | 900.00 | 360K | 603 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -6 | 753.76 | 5K | 51,974 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -35 | 755.91 | 26K | 51,939 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -16 | 757.68 | 12K | 51,923 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -24 | 758.16 | 18K | 51,899 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -14 | 759.96 | 11K | 51,885 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -74 | 760.65 | 56K | 51,811 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -27 | 761.36 | 21K | 51,784 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -55 | 762.57 | 42K | 51,729 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -25 | 763.76 | 19K | 51,704 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -219 | 764.40 | 167K | 51,485 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -271 | 765.39 | 207K | 51,214 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -279 | 766.47 | 214K | 50,935 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -192 | 767.39 | 147K | 50,743 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -105 | 768.33 | 81K | 50,638 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -127 | 769.30 | 98K | 50,511 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -12 | 770.20 | 9K | 50,499 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -283 | 771.56 | 218K | 50,216 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -211 | 772.56 | 163K | 50,005 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -224 | 773.40 | 173K | 49,781 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -121 | 774.48 | 94K | 49,660 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -376 | 775.46 | 292K | 49,284 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -66 | 776.31 | 51K | 49,218 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -38 | 777.76 | 30K | 49,180 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -454 | 778.64 | 354K | 48,726 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -380 | 779.59 | 296K | 48,346 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -463 | 780.63 | 361K | 47,883 |
| Oct 14, 2026 | Andrew J. Murphy | Co-Chief Scientific Officer | Sale (10b5-1) | -50 | 781.47 | 39K | 47,833 |
| Sep 3, 2026 | Marion McCourt | EVP Commercial | Sale (10b5-1) | -1,131 | 857.39 | 970K | 12,003 |
| Sep 2, 2026 | Marion McCourt | EVP Commercial | Sale (10b5-1) | -1,215 | 850.00 | 1.0M | 13,134 |
| Sep 2, 2026 | Kathryn Guarini | Director | Sale (10b5-1) | -400 | 850.00 | 340K | 603 |
| Aug 10, 2026 | Huda Y. Zoghbi | Director | Sale (10b5-1) | -800 | 800.00 | 640K | 1,703 |
| Aug 10, 2026 | Kathryn Guarini | Director | Sale (10b5-1) | -400 | 800.00 | 320K | 603 |
| Jul 2, 2026 | Arthur F. Ryan | Director | Sale (10b5-1) | -200 | 650.15 | 130K | 17,303 |